Monday, March 26, 2007

Some Major BUSINESS in PHARMACY INDUSTRY!

Collaborations of INDIAN Firms with FOREING BIGGIES

1) French biotech major Merieux Alliance picked up a 60 per cent stake in Hyderabad-based vaccine company, Shantha Biotechnics.
2) The US-based Merck & Co entered into a drug discovery and clinical collaboration with Advinus Therapeutics, the Tata-backed drug research and contract services company.

Different INDIAN Companies Doing WONDERS Abroad:

Companie:- Acquisitions
Wockhardt :- Ireland's Pinewood Laboratories
Matrix Labs :- Belgium's Docpharma
Dishman Pharma's :- Britain's Synprotec Limited
Dr Reddy's :- Germany's fourth largest drug company, Betapharm
Ranbaxy's :- Romanian pharma compan

Saturday, March 17, 2007

Clinical Trials In INDIA

A drug under development for a particular disease must undergo extensive studies in animals and humans to establish its safety and efficacy at a particular dose, prior to being marketed. Pharmaceutical companies allot a certain percentage of their revenue to be re-invested in drug development. Clinical trials represent a bridge from early stage drug development to commercialization. This bridge cannot be bypassed and is long and expensive to cross.

It takes approximately US$350 - $500 million to bring a drug from the lab to the market. This usually occurs over a widely varying time-span - 9 years on average.

It is because of this High Cost, Clinical Trials are a boom in INDIA. WIth cheap labour, high efficiency, Well-trained medical community to global standards and Large and fast growing private healthcare sector, india no longer could be left behind in this multi billion industry.
Estimates show that this industry in India would be worth more than $2 Billion by 2015.